SCHEMBL6434186

SCHEMBL6434186

CC1(C)Cc2sccc2C(=O)N1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.46
HPGD P15428 3/20 0.44
HSD17B10 Q99714 3/20 0.44
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
CDK5 Q00535 1/20 0.44
CDK5R1 Q15078 1/20 0.44
NCOA1 Q15788 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NCOA3 Q9Y6Q9 1/20 0.44
GFER P55789 1/20 0.44
CDC7 O00311 2/20 0.40
ALOX15 P16050 1/20 0.36
CES1 P23141 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TSHR P16473 1/20 0.33
BUB1 O43683 1/20 0.33
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9865110 0.71 CES1 (0.37) SMN1; SMN2CES1
SCHEMBL17837194 0.69 CES1 (0.35) HTTCDC7CES1
SCHEMBL7516513 0.69 ALDH1A1 (0.44) HTTHPGDHSD17B10KDM4EALDH1A1
SCHEMBL29964356 0.68 NPSR1 (0.62) HTTHPGDHSD17B10KDM4EALDH1A1
SCHEMBL4842012 0.68 NPSR1 (0.62) HTTHPGDHSD17B10KDM4EALDH1A1
SCHEMBL18112834 0.67 CES1 (0.34) HTTHPGDHSD17B10KDM4EALDH1A1
SCHEMBL25209666 0.67 CDC7 (0.47) HTTHPGDHSD17B10KDM4EALDH1A1
SCHEMBL4923925 0.67 HTT (0.54) HTTHPGDHSD17B10KDM4EALDH1A1
SCHEMBL18112841 0.67 CES1 (0.42) CES1
SCHEMBL27213311 0.67 MAPK1 (0.37) HTTHPGDHSD17B10KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1288203-B1 Cyclic nitrones and pharmaceutical compositions containing them AVENTIS PHARMA INC (US) 2005-04-20 EP disclosed
EP-1288203-A1 Cyclic nitrones and pharmaceutical compositions containing them Aventis Pharmaceuticals Inc. (US) 2003-03-05 EP disclosed
US-5962469-A PREVENTION OF OXIDATION TISSUE DAMAGE BY FREE RADICALS HOECHST MARION ROUSSEL INC. (US) 1999-10-05 US disclosed
EP-0863878-A1 CYCLIC NITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HOECHST MARION ROUSSEL, INC. (US) 1998-09-16 EP disclosed
WO-1997010218-A1 CYCLIC NITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HOECHST MARION ROUSSEL, INC. (US) 1997-03-20 WO disclosed